Clinical Trial Update: Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected Adults [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept study evaluating oral VH4004280 or VH4011499 in adults with HIV infection has completed enrollment and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• VH4004280
• VH4011499

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2025-09-30